<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1303245045
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LEUKAIR 10MG F.C.TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MONTELUKAST SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        71.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SAUDI PHARMACEUTICAL INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1023]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R03DC03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Leukair is a leukotriene receptor antagonist that blocks substances called leukotrienes.</p><p><strong>How Leukair works</strong><br />Leukotrienes cause narrowing and swelling of airways in the lungs and also cause allergy symptoms. By blocking leukotrienes, Leukair improves asthma symptoms, helps control asthma and improves seasonal allergy symptoms (also known as hay fever or seasonal allergic rhinitis).</p><p><strong>When Leukair should be used</strong><br />Your doctor has prescribed Leukair to treat asthma, preventing your asthma symptoms during the day and night.</p><ul><li>Leukair is used for the treatment of adults and adolescents 15 years of age and older who are not adequately controlled on their medication and need additional therapy.</li><li>Leukair also helps prevent the narrowing of airways triggered by exercise.</li><li>In those asthmatic patients in whom Leukair is indicated in asthma, Leukair can also provide symptomatic relief of seasonal allergic rhinitis.</li><li>Leukair is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older. (See section 2 for the use of this product in patients less than 15 years).</li></ul><p>Your doctor will determine how Leukair should be used depending on the symptoms and severity of your asthma.</p><p><strong>What is asthma?</strong><br />Asthma is a long-term disease.<br />Asthma includes:</p><ul><li>difficulty breathing because of narrowed airways. This narrowing of airways worsens and improves in response to various conditions.</li><li>sensitive airways that react to many things, such as cigarette smoke, pollen, cold air, or exercise.</li><li>swelling (inflammation) in the lining of airways.</li></ul><p>Symptoms of asthma include: Coughing, wheezing, and chest tightness.</p><p><strong>What are seasonal allergies?</strong><br />Seasonal allergies (also known as hay fever or seasonal allergic rhinitis) are an allergic response often caused by airborne pollens from trees, grasses and weeds. The symptoms of seasonal allergies typically may include: stuffy, runny, itchy nose; sneezing; watery, swollen, red, itchy eyes.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Tell your doctor about any medical problems or allergies you have now or have had.</p><p><strong>Do not take Leukair</strong><br />If you are allergic to montelukast or any of the other ingredients of this medicine (listed in section 6).</p><p><strong>Warnings and Precautions</strong><br />Talk to your doctor or pharmacist before taking Leukair.</p><ul><li>If your asthma or breathing gets worse, tell your doctor immediately.</li><li>Leukair is not meant to treat acute asthma attacks. If an attack occurs, follow the instructions your doctor has given you. Always have your inhaled rescue medicine for asthma attacks with you.</li><li>It is important that you or your child take all asthma medications prescribed by your doctor. Leukair should not be substituted for other asthma medications your doctor has prescribed for you.</li><li>Any patient on anti-asthma medicines should be aware that if you develop a combination of symptoms such as a flu-like illness, pins and needles or numbness of arms or legs, worsening of pulmonary symptoms, and/or rash, you should consult your doctor.</li><li>You should not take acetyl-salicylic acid (aspirin) or anti-inflammatory medicines (also known as non-steroidal anti-inflammatory drugs or NSAIDs) if they make your asthma worse.</li></ul><p>Patients should be aware that various neuropsychiatric events (for example behaviour and mood-related changes) have been reported in adults, adolescents and children with montelukast (see section 4). If you develop such symptoms while taking Leukair, you should consult your doctor.</p><p><strong>Children and adolescents</strong><br />Do not give Leukair 10 mg film-coated tablets to children less than 15 years of age.</p><p><strong>Other medicines and Leukair</strong><br />Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines including those obtained without a prescription.<br />Some medicines may affect how Leukair works, or Leukair may affect how other medicines work.<br />Tell your doctor if you are taking the following medicines before starting Leukair:</p><ul><li>phenobarbital (used for treatment of epilepsy)</li><li>phenytoin (used for treatment of epilepsy)</li><li>rifampicin (used to treat tuberculosis and some other infections)</li><li>gemfibrozil (used for treatment of high lipid levels in plasma)</li></ul><p><strong>Leukair with food, drink and alcohol</strong><br />Leukair may be taken with or without food.</p><p><strong>Pregnancy and breast-feeding</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking Leukair.</p><p><u>Pregnancy</u><br />Your doctor will assess whether you can take Leukair during this time.</p><p><u>Breast-feeding</u><br />It is not known if Leukair appears in breast milk. You should consult your doctor before taking Leukair if you are breast-feeding or intend to breast-feed.<strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong><br />Leukair is not expected to affect your ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported with Leukair may affect some patients&rsquo; ability to drive or operate machinery.</p><p><strong>Leukair contains lactose</strong><br />If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><ul><li>You should take only one tablet of Leukair once a day as prescribed by your doctor.</li><li>It should be taken even when you have no symptoms or have an acute asthma attack.</li></ul><p><strong>For adults and adolescents 15 years of age and older:</strong><br />The recommended dose is one 10 mg tablet to be taken daily in the evening.<br />If you are taking Leukair, be sure that you do not take any other products that contain the same active ingredient, montelukast.<br />This medicine is for oral use.<br />You can take Leukair with or without food.<strong>&nbsp;</strong></p><p><strong>If you take more Leukair than you should</strong><br />Contact your doctor immediately for advice.<br />There were no side effects reported in the majority of overdose reports. The most frequently occurring symptoms reported with overdose in adults and children included abdominal pain, sleepiness, thirst, headache, vomiting, and hyperactivity.<strong>&nbsp;</strong></p><p><strong>If you forget to take Leukair</strong><br />Try to take Leukair as prescribed. However, if you miss a dose, just resume the usual schedule of one tablet once daily.<br />Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop taking Leukair</strong><br />It is important to continue taking Leukair for as long as your doctor prescribes. It will help control your asthma.<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>In clinical studies with montelukast, the most commonly reported side effects (occurring in at least 1 of 100 patients and less than 1 of 10 patients treated) thought to be related to montelukast were:</p><ul><li>abdominal pain</li><li>headache</li></ul><p>These were usually mild and occurred at a greater frequency in patients treated with montelukast than placebo (a pill containing no medication).<br />The frequency of possible side effects listed below is defined using the following convention:<br />Very common: may affect more than 1 in 10 people<br />Common: may affect up to 1 in 10 people<br />Uncommon: may affect up to 1 in 100 people<br />Rare: may affect up to 1 in 1,000 people<br />Very rare: may affect up to 1 in 10,000 people<br />Not known: frequency cannot be estimated from the available data</p><p>Additionally, while montelukast has been on the market, the following have been reported:</p><ul><li>upper respiratory infection <em>(Very common)</em></li><li>increased bleeding tendency <em>(Rare)</em></li><li>allergic reactions including swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing <em>(Uncommon)</em></li><li><em>behaviour and mood related changes [dream abnormalities, insomnia (trouble sleeping), somnambulism (sleep walking), tic, irritability, anxiousness, restlessness, agitation, aggressive behaviour or hostility, depression (Uncommon); tremor, disturbance in attention, memory impairment (Rare); hallucinations, disorientation, suicidal thinking and behavior (including suicicde), dysphemia (stuttering), obsessive-compulsive symptoms (Very rare)].</em></li><li>behaviour and mood related changes [dream abnormalities, including nightmares, trouble sleeping, sleep walking, irritability, feeling anxious, restlessness, agitation including aggressive behaviour or hostility, depression <em>(Uncommon)</em>; tremor, disturbance in attention, memory impairment <em>(Rare)</em>; hallucinations, disorientation, suicidal thoughts and actions <em>(Very rare)</em>]</li><li>dizziness, drowsiness, pins and needles/numbness, seizure <em>(Uncommon)</em></li><li>palpitations <em>(Rare)</em></li><li>nosebleed <em>(Uncommon)</em>, swelling (inflammation) of the lungs <em>(Very rare)</em></li><li>diarrhoea, nausea, vomiting <em>(Common)</em>; dry mouth, indigestion <em>(Uncommon)</em></li><li>hepatitis (inflammation of the liver) <em>(Very rare)</em></li><li>rash <em>(Common)</em>; bruising, itching, hives <em>(Uncommon)</em>; tender red lumps under the skin most commonly on your shins (erythema nodosum), severe skin reactions (erythema multiforme) that may occur without warning <em>(Very rare)</em></li><li>joint or muscle pain, muscle cramps <em>(Uncommon)</em></li><li>fever <em>(Common)</em>; weakness/tiredness, feeling unwell, swelling <em>(Uncommon)</em></li></ul><p>In asthmatic patients treated with montelukast, very rare cases of a combination of symptoms such as flu-like illness, pins and needles or numbness of arms and legs, worsening of pulmonary symptoms and/or rash (Churg-Strauss syndrome) have been reported. You must tell your doctor right away if you get one or more of these symptoms (See section 2).<br />If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Do not store above 30&deg;C.<br />Do not use this medicine after the expiry date which is stated on the strip and carton. The expiry date refers to the last day of that month.<br />Do not throw away any medicines via wastewater or household waste. Ask the pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>The active substance is montelukast. Each film-coated tablet contains montelukast sodium which corresponds to 10 mg of montelukast.&#39;</li><li>The other ingredients are:<ul><li>Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium and magnesium stearate.</li><li>Film coating: Opadry AMB 80W27179, ethanol and purified water.</li></ul></li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Leukair 10 mg film-coated tablets are pale yellow colored round, biconvex film coated tablets plain on both surfaces.
Leukair is available as 28 film-coated tablets carton pack containing 4 strips (7 tablets each).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Saudi Pharmaceutical Industries<br />P.O. Box No.: 355127, Riyadh 11383<br />Kingdom of Saudi Arabia.<br />Tel: (+96611) 2650450, 2650354<br />Fax: (+96611) 2650383<br />Email: info@saudi-pharma.net</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                07/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>ليوكير هو مضاد لمستقبلة اللوكوتريين حيث يقوم بإحصار مواد تدعى لوكوتريينات.</p><p><strong>كيف يعمل ليوكير</strong><br />تسبب اللوكوتريينات تضيقاً وتورماً في المسالك الهوائية في الرئتين وتسبب أيضاً أعراض الحساسية. ومن خلال إحصار اللوكوتريينات فإن ليوكير يحسن أعراض الربو ويساعد في السيطرة على الربو ويحسن أعراض الحساسية الموسمية (المعروفة أيضاً بحمى الكلأ أو التهاب الأنف التحسسي الموسمي).</p><p><strong>متى يجب استخدام ليوكير</strong><br />لقد قام طبيبك بوصف ليوكير ليعالج الربو أو يقيك من أعراض الربو خلال النهار والليل.</p><ul><li>يستخدم ليوكير لمعالجة البالغين والمراهقين بعمر 15 سنة وما فوق الذين لا تتم السيطرة على المرض عندهم بشكل كاف من خلال أدويتهم التي يستخدمونها ويحتاجون إلى معالجة إضافية.</li><li>يساعد ليوكير أيضاً على الوقاية من تضيق المسالك الهوائية الناجم عن التمرين.</li><li>عندما يوصف ليوكير لمرضى الربو فإنه يمكن أن يخفف أيضاً أعراض التهاب الأنف التحسسي الموسمي لديهم.</li><li>يوصف ليوكير لتخفيف أعراض التهاب الأنف التحسسي الموسمي للمرضى بعمر سنتين فأكثر والتهاب الأنف التحسسي اللاموسمي (التهاب الأنف المستمر) للمرضى بعمر 6 شهور فأكثر. (انظر القسم 2 لاستخدام هذا الدواء في المرضى بعمر أقل من 15 سنة).</li></ul><p>سيقوم طبيبك بتحديد كيفية استخدام ليوكير اعتماداً على أعراض وشدة الربو لديك.</p><p><strong>ما هو الربو؟</strong><br />الربو مرض طويل الأمد.<br />يتضمن الربو:</p><ul><li>صعوبة في التنفس بسبب تضيق المسالك الهوائية. هذا التضيق في المسالك الهوائية يسوء ويتحسن استجابة للظروف المختلفة.</li><li>مسالك هوائية حساسة تستجيب لأشياء عديدة، مثل دخان السجائر أو غبار الطلع أو الهواء البارد أو التمرين.</li><li>تورماً (التهاباً) في بطانة المسالك الهوائية.</li></ul><p>تتضمن أعراض الربو: سعالاً وأزيزاً وضيقاً في الصدر.</p><p><strong>ما هي حالات الحساسية الموسمية؟</strong><br />حالات الحساسية الموسمية (تعرف أيضاً بحمى الكلأ أو التهاب الأنف التحسسي الموسمي) هي استجابة تحسسية غالباً ما تكون بسبب غبار الطلع المنقول بالهواء من الأشجار والأعشاب والحشائش الضارة. إن الأعراض النموذجية لحالات الحساسية الموسمية قد تتضمن: انسداداً وحكة وسيلاناً في الأنف؛ عطاساً؛ دموعاً وتورماً واحمراراً وحكة في العين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>أخبر طبيبك عن أية مشاكل طبية أو حالات تحسسية تعاني منها في الوقت الحالي أو قد عانيت منها سابقاً.</p><p><strong>لا تتناول ليوكير:</strong><br />إذا كنت حساساً لمونتيلوكاست أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم 6).<strong>&nbsp;</strong></p><p><strong>تحذيرات واحتياطات</strong><br />تكلم مع طبيبك أو الصيدلي قبل تناول ليوكير.</p><ul><li dir="rtl">إذا كان الربو أو التنفس لديك يزدادان سوءاً فأخبر طبيبك على الفور.</li><li dir="rtl">لا يعتبر ليوكير علاجاً لنوبات الربو الحادة. إذا حدثت نوبة ربو فاتبع التعليمات التي أوصاك بها طبيبك. أبق معك دائماً دوائك الاستنشاقي الإسعافي الذي تستخدمه لنوبات الربو.</li><li dir="rtl">من المهم بأن تتناول أنت أو طفلك جميع علاجات الربو الموصوفة من قبل طبيبك. يجب ألا تستبدل علاجات الربو الأخرى التي وصفها لك طبيبك بليوكير.</li><li dir="rtl">يجب على كل مريض يستخدم علاجاً مضاداً للربو أن يكون حذراً وإذا تطور لديك مزيج من الأعراض مثل الأعراض المماثلة للأنفلونزا و/أو الإحساس بما يشبه وخز الدبابيس والإبر أو النمل في الذراعين أو الساقين و/أو ازدياد سوء الأعراض الرئوية و/أو الطفح فإنه يجب عليك استشارة طبيبك.</li><li dir="rtl">يجب عليك ألا تتناول حمض الأسيتيل ساليسيليك (الأسبرين) أو الأدوية المضادة للالتهاب (المعروفة أيضاً بمضادات الالتهاب اللاستيرويدية أو NSAIDs) إذا كانت تزيد سوء حالة الربو لديك.</li></ul><p dir="RTL">يجب أن يكون المرضى على دراية بورود عدة تقارير عن أحداث نفسية عصبية (على سبيل المثال تغيرات مرتبطة بالسلوك والمزاج) لدى البالغين والمراهقين والأطفال ترافقت مع استخدام مونتيلوكاست (انظر القسم 4). إذا تطورت لديك مثل هذه الأعراض أثناء تناولك لليوكير فيجب أن تقوم باستشارة طبيبك.</p><p><strong>الأطفال والمراهقون</strong><br />لا تعطِ أقراص ليوكير 10 ملغ المغلفة للأطفال بعمر أقل من 15 سنة.</p><p><strong>الأدوية الأخرى وليوكير</strong><br />أخبر طبيبك أو الصيدلي إذا كنت تتناول أو قد تناولت مؤخراً أو ربما تتناول أدوية أخرى بما في ذلك الأدوية التي يتم الحصول عليها دون وصفة طبية.<br />قد تؤثر بعض الأدوية على آلية عمل ليوكير أو قد يؤثر ليوكير على آلية عمل الأدوية الأخرى.<br />أخبر طبيبك إذا كنت تتناول الأدوية التالية قبل أن تبدأ باستخدام ليوكير:</p><ul><li>فينوباربيتال (يستخدم لمعالجة الصرع).</li><li>فينيتوين (يستخدم لمعالجة الصرع).</li><li>ريفامبيسين (يستخدم لمعالجة السل وبعض العداوى الأخرى).</li><li>جيمفيبروزيل (يستخدم لمعالجة المستويات المرتفعة من الشحوم في البلازما).</li></ul><p><strong>ليوكير مع الطعام والشراب والكحول</strong><br />يمكن تناول ليوكير مع الطعام أو دونه.</p><p><strong>الحمل والإرضاع</strong><br />إذا كنت حاملاً أو مرضعة أو تعتقدين بأنك حامل أو تخططين للحمل فاستشيري طبيبك أو الصيدلي قبل تناول ليوكير.</p><p><u>الحمل</u><br />سيقوم طبيبك بتقييم إمكانية تناولك لليوكير خلال هذه الفترة.</p><p><u>الإرضاع</u><br />من غير المعروف ما إذا كان ليوكير يظهر في الحليب. ينبغي عليك استشارة طبيبك قبل تناول ليوكير إذا كنت مرضعة أو تنوين الإرضاع.</p><p><strong>القيادة واستخدام الآلات</strong><br />من غير المتوقع أن يؤثر ليوكير على قدرتك على قيادة السيارة أو تشغيل الآلات. وعلى أية حال فقد تختلف الاستجابات الفردية تجاه الدواء. إن بعض الأعراض الجانبية (مثل الدوخة والنعاس) التي تم تسجيل حدوثها مع استخدام ليوكير قد تؤثر على قدرة بعض المرضى على القيادة أو تشغيل الآلات.</p><p><strong>ليوكير يحتوي على اللاكتوز</strong><br />إذا أخبرك طبيبك أن لديك عدم تحمل لبعض السكريات فاتصل بطبيبك قبل تناول هذا المنتج الدوائي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول هذا الدواء دائماً كما أخبرك طبيبك أو الصيدلي. يجب أن تراجع طبيبك أو الصيدلي إذا لم تكن متأكداً.</p><ul><li>يجب أن تتناول قرصاً واحداً فقط من ليوكير مرة واحدة يومياً كما وصف لك طبيبك.</li><li>يجب أن تقوم بتناوله إن لم تكن لديك أعراض أو إذا كنت تعاني من نوبة ربو حادة على حد سواء.</li></ul><p><strong>للبالغين والمراهقين بعمر 15 سنة فما فوق</strong><br />الجرعة الموصى بها هي قرص 10 ملغ واحد يؤخذ يومياً في المساء.<br />إذا كنت تتناول ليوكير فتأكد من أنك لا تتناول أي منتج آخر يحتوي على المكون الفعال نفسه، مونتيلوكاست.<br />هذا الدواء يستخدم عن طريق الفم.<br />يمكنك تناول ليوكير مع أو دون الطعام.</p><p><strong>إذا تناولت ليوكير أكثر مما ينبغي</strong><br />اتصل بطبيك في الحال للحصول على المشورة الطبية.<br />لم يسجل حدوث أعراض جانبية في معظم تقارير الجرعة الزائدة. تضمنت الحوادث المسجلة الأكثر تكراراً للجرعة الزائدة لدى البالغين والأطفال الألم البطني والنعاس والعطش والصداع والقيء وفرط النشاط.</p><p><strong>إذا نسيت أن تتناول ليوكير</strong><br />حاول أن تتناول ليوكير كما وصف لك. على أية حال، إذا نسيت تناول جرعة فعليك فقط أن تستأنف جدولك اليومي المعتاد لقرص واحد مرة واحدة يومياً.<br />لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية.</p><p><strong>إذا توقفت عن تناول ليوكير</strong><br />من المهم أن تستمر في تناول ليوكير طوال المدة التي يحددها لك طبيبك. لأن ذلك سيساعدك في السيطرة على الربو لديك.<br />إذا كانت لديك أية أسئلة أخرى حول استخدام هذا الدواء فاسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن لهذا الدواء أن يسبب أعراضاً جانبية إلا أنها قد لا تحدث لدى كل الأشخاص.<br />في الدراسات السريرية على مونتيلوكاست، وجد أن الأعراض الجانبية المسجلة الأكثر شيوعاً (تحدث لدى 1 على الأقل من 100 مريض ولدى أقل من 1 من 10 مرضى تتم معالجتهم) التي تكون مرتبطة بمونتيلوكاست هي:</p><ul><li>ألم بطني.</li><li>صداع.</li></ul><p>تكون هذه الأعراض عادة خفيفة وتحدث بمعدل أكبر لدى المرضى الذين تمت معالجتهم بمونتيلوكسات مقارنة بأولئك الذين تناولوا دواء وهمياً (أقراصاً لا تحتوي على دواء).<br />تم تعريف معدلات حدوث الأعراض الجانبية المحتملة المدرجة أدناه باستخدام الاصطلاحات التالية:<br />شائعة جداً: يمكن أن تؤثر على أكثر من 1 من 10 أشخاص<br />شائعة: يمكن أن تؤثر على 1 من 10 أشخاص<br />غير شائعة: يمكن أن تؤثر على 1 من 100 شخص<br />نادرة: يمكن أن تؤثر على 1 من 1000 شخص<br />نادرة جداً: يمكن أن تؤثر على 1 من 10000 شخص<br />غير معروفة: لا يمكن تقييم معدل حدوثها من خلال البيانات المتاحة<br />إضافة إلى ذلك، تم تسجيل الأعراض التالية بعد طرح مونتيلوكاست في السوق:</p><ul><li>عدوى بالجهاز التنفسي العلوي <em>(شائعة جداً)</em></li><li>زيادة قابلية النزف <em>(نادرة)</em></li><li>تفاعلات تحسسية تتضمن تورماً في الوجه و/أو الشفاه و/أو اللسان و/أو الحلق والتي يمكن أن تسبب صعوبة في التنفس أو البلع <em>(غير شائعة)</em></li><li>تغيرات متعلقة بالسلوك والمزاج [اضطرابات في الأحلام، أرق (اضطراب النوم)، المشي أثناء النوم (سير نومي)، عرة (حركات تقلصية لا إرادية)، تهيج، قلق، تململ، هياج، سلوك عدواني أو حقد، اكتئاب <em>(غير شائعة)</em>؛ رعاش، اضطراب في الانتباه، ضعف في الذاكرة <em>(نادرة)</em>؛ هلوسات، توهان، أفكار وأفعال انتحارية (بما في ذلك الانتحار)، تأتأة نفسية المنشأ، أعراض وسواس قهري <em>(نادرة جداً)</em>]</li><li>دوخة، نعاس، إحساس بما يشبه وخز الدبابيس والإبر/نمل، نوبة تشنجية <em>(غير شائعة)</em></li><li>خفقان <em>(نادر)</em></li><li>رعاف <em>(غير شائع)؛ </em>تورم (التهاب) الرئتين <em>(نادر جداً)</em></li><li>إسهال، غثيان، قيء <em>(شائعة)؛</em> جفاف الفم، عسر الهضم <em>(غير شائع)</em></li><li>التهاب الكبد <em>(نادر جداً)</em></li><li>طفح <em>(شائع)؛</em> تكدم، حكة، شرى <em>(غير شائع)؛</em> كتل حمراء طرية تحت الجلد (حُمامى عَقِدة) شائعة بكثرة على قصبتي الساقين (عظام الظنبوب)، ردود فعل جلدية شديدة (حُمامى عديدة الأشكال) والتي يمكن أن تحدث دون سابق إنذار <em>(نادرة جداً)</em></li><li>ألم في المفاصل أو العضلات، تقلصات عضلية <em>(غير شائعة)</em></li><li>حمى <em>(شائعة)؛</em> ضعف/تعب، شعور بعدم الارتياح، تورم <em>(غير شائعة)</em></li></ul><p>لدى مرضى الربو المعالجين بمونتيلوكاست، سجلت حالات نادرة جداً من التعرض لمزيج من الأعراض مثل الأعراض المماثلة للأنفلونزا و/أو الإحساس بما يشبه وخز الدبابيس والإبر أو النمل في الذراعين والساقين و/أو ازدياد سوء الأعراض الرئوية و/أو طفح (متلازمة شيرغ-ستراوس). يجب عليك أن تخبر طبيبك فوراً إذا تعرضت لواحد أو أكثر من هذه الأعراض (انظر القسم 2).<br />إذا أصبت بأية أعراض جانبية فتحدث إلى طبيبك أو الصيدلي. هذا يشمل أيضاً أية أعراض جانبية محتملة غير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول ومرأى الأطفال.<br />يخزن عند حرارة لا تزيد عن 30&deg;م.<br />لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية الموضح على الشريط والعبوة الخارجية. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من ذلك الشهر.<br />لا تقم بالتخلص من الأدوية من خلال مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تحتاجها. ستساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li dir="rtl">المادة الفعالة هي مونتيلوكاست. يحتوي كل قرص مغلف على مونتيلوكاست صوديوم ما يكافئ 10 ملغ من مونتيلوكاست.</li><li dir="rtl">المكونات الأخرى هي:<ul><li>اللاكتوز أحادي الهيدرات والسلولوز البلوري المكروي وصوديوم كروس كارميلوز وستيارات المغنيزيوم.</li><li>التغليف: أوبادري AMB 80W27179 وإيثانول وماء منقى.</li></ul></li></ul>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص ليوكير 10 ملغ المغلفة عبارة عن أقراص صفراء شاحبة اللون مستديرة محدبة الوجهين مغلفة بالفلم ملساء من كلا الوجهين.<br />يتوفر ليوكير في عبوات كرتونية تحتوي على 28 قرصاً مغلفاً في 4 أشرطة (7 أقراص في كل شريط).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة السعودية للصناعات الصيدلانية<br />صندوق بريد رقم: 355127، الرياض 11383<br />المملكة العربية السعودية.<br />هاتف: 2650354، 2650450 (96611+)<br />فاكس: 2650383 (96611+)<br />بريد الكتروني: info@saudi-pharma.net</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            07/2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Leukair 10 mg film-coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One film-coated tablet contains montelukast sodium, which is equivalent to 10 mg montelukast.
Excipient with known effect: This medicine contains 85.3 mg lactose monohydrate per tablet.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet.
Pale yellow colored round, biconvex film coated tablets plain on both surfaces.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Leukair is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom &ldquo;as-needed&rdquo; short acting &beta;-agonists provide inadequate clinical control of asthma. In those asthmatic patients in whom Leukair is indicated in asthma, Leukair can also provide symptomatic relief of seasonal allergic rhinitis.<br />Leukair is also indicated in the prophylaxis of asthma in which the predominant component is exercise-induced bronchoconstriction.<br />Leukair is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older. Because the benefits of Leukair may not outweigh the risk of neuropsychiatric symptoms in patients with allergic rhinitis (see section 4.4 Special warnings and precautions for use), reserve use for patients who have an inadequate response or intolerance to alternative therapies. For patients less than 15 years, see section 4.2 Posology and method of administration).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u><br />The recommended dose for adults and adolescents 15 years of age and older with asthma, or with asthma and concomitant seasonal allergic rhinitis, is one 10 mg tablet daily to be taken in the evening.</p><p><u>General recommendations</u><br />The therapeutic effect of Leukair on parameters of asthma control occurs within one day. Leukair may be taken with or without food. Patients should be advised to continue taking Leukair even if their asthma is under control, as well as during periods of worsening asthma. Leukair should not be used concomitantly with other products containing the same active ingredient, montelukast.<br />No dosage adjustment is necessary for the elderly, or for patients with renal insufficiency, or mild to moderate hepatic impairment. There are no data on patients with severe hepatic impairment. The dosage is the same for both male and female patients.</p><p><u>Therapy with Leukair in relation to other treatments for asthma</u><br />Leukair can be added to a patient&#39;s existing treatment regimen.</p><p><em>Inhaled corticosteroids: </em>Treatment with Leukair can be used as add-on therapy in patients when inhaled corticosteroids plus &ldquo;as needed&rdquo; short acting &beta;-agonists provide inadequate clinical control. Leukair should not be abruptly substituted for inhaled corticosteroids (see section 4.4).</p><p><em>Paediatric population</em><br />Do not give Leukair 10 mg film-coated tablets to children less than 15 years of age. The safety and efficacy of Leukair 10 mg film-coated tablets in children less than 15 years has not been established.</p><p><u>Method of administration</u><br />Oral use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should be advised never to use oral montelukast to treat acute asthma attacks and to keep their usual appropriate rescue medication for this purpose readily available. If an acute attack occurs, a short-acting inhaled &beta;-agonist should be used. Patients should seek their doctors&#39; advice as soon as possible if they need more inhalations of short-acting &beta;-agonists than usual.<br />Montelukast should not be substituted abruptly for inhaled or oral corticosteroids.<br />There are no data demonstrating that oral corticosteroids can be reduced when montelukast is given concomitantly.<br />In rare cases, patients on therapy with anti-asthma agents including montelukast may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with Churg-Strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. These cases have been sometimes associated with the reduction or withdrawal of oral corticosteroid therapy. Although a causal relationship with leukotriene receptor antagonism has not been established, physicians should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. Patients who develop these symptoms should be reassessed and their treatment regimens evaluated.<br />Treatment with montelukast does not alter the need for patients with aspirin-sensitive asthma to avoid taking aspirin and other non-steroidal anti-inflammatory drugs.<br />Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p><p>Serious neuropsychiatric (NP) events have been reported with use of Leukair. These postmarketing reports have been highly variable and included, but were not limited to, agitation, aggressive behavior or hostility, anxiousness, depression, disorientation, disturbance in attention, dream abnormalities, dysphemia (stuttering), hallucinations, insomnia, irritability, memory impairment, obsessive-compulsive symptoms, restlessness, somnambulism, suicidal thoughts and behavior (including suicide), tic, and tremor. NP events have been reported in adult, adolescent, and pediatric patients with and without a previous history of psychiatric disorder. NP events have been reported mostly during Leukair treatment, but some were reported after Leukair discontinuation. Animal studies showed that montelukast distributes into the brain in rats (see 5.2 Pharmacokinetic properties); however, the mechanisms underlying Leukair -associated NP events are currently not well understood. Based upon the available data, it is difficult to identify risk factors for or quantify the risk of NP events with Leukair use.<br />Because of the risk of NP events, the benefits of Leukair may not outweigh the risks in some patients, particularly when the symptoms of disease may be mild and adequately treated with alternative therapies. Reserve use of Leukair for patients with allergic rhinitis who have an inadequate response or intolerance to alternative therapies (see section 4.1 Therapeutic indications). In patients with asthma or exercise-induced bronchoconstriction, consider the benefits and risks before prescribing Leukair.<br />Discuss the benefits and risks of Leukair use with patients and caregivers when prescribing Leukair. Advise patients and/or caregivers to be alert for changes in behavior or for new NP symptoms when taking Leukair. If changes in behavior are observed, or if new NP symptoms or suicidal thoughts and/or behavior occur, advise patients to discontinue Leukair and contact a healthcare provider immediately. In many cases, symptoms resolved after stopping Leukair therapy; however, in some cases symptoms persisted after discontinuation of Leukair. Therefore, continue to monitor and provide supportive care until symptoms resolve. Re-evaluate the benefits and risks of restarting treatment with Leukair if such events occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Montelukast may be administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma. In drug-interactions studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following medicinal products: theophylline, prednisone, prednisolone, oral contraceptives (ethinyl estradiol/norethindrone 35/1), terfenadine, digoxin and warfarin.<br />The area under the plasma concentration curve (AUC) for montelukast was decreased approximately 40% in subjects with co-administration of phenobarbital. Since montelukast is metabolised by CYP 3A4, 2C8, and 2C9, caution should be exercised, particularly in children, when montelukast is co-administered with inducers of CYP 3A4, 2C8, and 2C9, such as phenytoin, phenobarbital and rifampicin.<br /><em>In vitro</em> studies have shown that montelukast is a potent inhibitor of CYP 2C8. However, data from a clinical drug-drug interaction study involving montelukast and rosiglitazone (a probe substrate representative of medicinal products primarily metabolized by CYP 2C8) demonstrated that montelukast does not inhibit CYP 2C8 <em>in vivo</em>. Therefore, montelukast is not anticipated to markedly alter the metabolism of medicinal products metabolised by this enzyme (e.g., paclitaxel, rosiglitazone, and repaglinide).<br /><em>In vitro</em> studies have shown that montelukast is a substrate of CYP 2C8, and to a less significant extent, of 2C9, and 3A4. In a clinical drug-drug interaction study involving montelukast and gemfibrozil (an inhibitor of both CYP 2C8 and 2C9) gemfibrozil increased the systemic exposure of montelukast by 4.4-fold. No routine dosage adjustment of montelukast is required upon co-administration with gemfibrozil or other potent inhibitors of CYP 2C8, but the physician should be aware of the potential for an increase in adverse reactions.<br />Based on <em>in vitro</em> data, clinically important drug interactions with less potent inhibitors of CYP 2C8 (e.g., trimethoprim) are not anticipated. Co-administration of montelukast with itraconazole, a strong inhibitor of CYP 3A4, resulted in no significant increase in the systemic exposure of montelukast.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u><br />Animal studies do not indicate harmful effects with respect to effects on pregnancy or embryonal/foetal development.<br />Limited data from available pregnancy databases do not suggest a causal relationship between montelukast and malformations (i.e. limb defects) that have been rarely reported in worldwide post-marketing experience.<br />Leukair may be used during pregnancy only if it is considered to be clearly essential.</p><p><u>Breast-feeding</u><br />Studies in rats have shown that montelukast is excreted in milk (see section 5.3). It is unknown whether montelukast/metabolites are excreted in human milk.<br />Leukair may be used in breast-feeding only if it is considered to be clearly essential.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Leukair has no or negligible influence on the ability to drive and use machines. However, individuals have reported drowsiness or dizziness.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Montelukast has been evaluated in clinical studies as follows:</p><ul><li>10 mg film-coated tablets in approximately 4,000 adult and adolescent asthmatic patients 15 years of age and older.</li><li>10 mg film-coated tablets in approximately 400 adult and adolescent asthmatic patients with seasonal allergic rhinitis 15 years of age and older.</li><li>5 mg chewable tablets in approximately 1,750 paediatric asthmatic patients 6 to 14 years of age.</li></ul><p>The following drug-related adverse reactions in clinical studies were reported commonly (&ge;1/100 to &lt;1/10) in asthmatic patients treated with montelukast and at a greater incidence than in patients treated with placebo:</p><table border="1" cellspacing="0" cellpadding="0" style="width:693px"><tbody><tr><td style="width:177px"><p><strong>Body System Class</strong></p></td><td style="width:294px"><p><strong>Adult and Adolescent Patients 15 years and older (two 12-week studies; n=795)</strong></p></td><td style="width:219px"><p><strong>Paediatric Patients 6 to 14 years old</strong></p><p><strong>(one 8-week study; n=201)</strong></p><p><strong>(two 56-week studies; n=615)</strong></p></td></tr><tr><td style="width:177px"><p><strong>Nervous system disorders</strong></p></td><td style="width:294px"><p>Headache</p></td><td style="width:219px"><p>Headache</p></td></tr><tr><td style="width:177px"><p><strong>Gastro-intestinal disorders</strong></p></td><td style="width:294px"><p>Abdominal pain</p></td><td style="width:219px"><p>&nbsp;</p></td></tr></tbody></table><p>With prolonged treatment in clinical trials with a limited number of patients for up to 2 years for adults, and up to 12 months for paediatric patients 6 to 14 years of age, the safety profile did not change.</p><p><u>Tabulated list of Adverse Reactions</u><br />Adverse reactions reported in post-marketing use are listed, by System Organ Class and specific Adverse Reactions, in the table below. Frequency Categories were estimated based on relevant clinical trials.</p><table border="1" cellspacing="0" cellpadding="0" style="width:770px"><tbody><tr><td><p><strong>System Organ Class</strong></p></td><td><p><strong>Adverse Reactions</strong></p></td><td><p><strong>Frequency Category*</strong></p></td></tr><tr><td><p>Infections and infestations</p></td><td><p>upper respiratory infection<sup>&dagger;</sup></p></td><td><p>Very Common</p></td></tr><tr><td><p>Blood and lymphatic system disorders</p></td><td><p>increased bleeding tendency</p></td><td><p>Rare</p></td></tr><tr><td rowspan="2"><p>Immune system disorders</p></td><td><p>hypersensitivity reactions including anaphylaxis</p></td><td><p>Uncommon</p></td></tr><tr><td><p>hepatic eosinophilic infiltration</p></td><td><p>Very Rare</p></td></tr><tr><td rowspan="3"><p>Psychiatric disorders</p></td><td><p>agitation, aggressive behavior or hostility, anxiousness, depression, dream abnormalities, insomnia, irritability, restlessness, somnambulism, tic, (see Boxed Warning and section 4.4 Special warnings and precautions for use).</p></td><td><p>Uncommon</p></td></tr><tr><td><p>disturbance in attention, memory impairment, tremor, (see Boxed Warning and section 4.4 Special warnings and precautions for use).</p></td><td><p>Rare</p></td></tr><tr><td><p>hallucinations, disorientation, suicidal thinking and behaviour (including suicide), dysphemia (stuttering), obsessive-compulsive symptoms, (see Boxed Warning and section 4.4 Special warnings and precautions for use).</p></td><td><p>Very Rare</p></td></tr><tr><td><p>Nervous system disorders</p></td><td><p>dizziness, drowsiness, paraesthesia/hypoesthesia, seizure</p></td><td><p>Uncommon</p></td></tr><tr><td><p>Cardiac disorders</p></td><td><p>Palpitations</p></td><td><p>Rare</p></td></tr><tr><td rowspan="3"><p>Respiratory, thoracic and mediastinal disorders</p></td><td><p>epistaxis</p></td><td><p>Uncommon</p></td></tr><tr><td><p>Churg-Strauss Syndrome (CSS) (see section 4.4)</p></td><td><p>Very Rare</p></td></tr><tr><td><p>pulmonary eosinophilia</p></td><td><p>Very Rare</p></td></tr><tr><td rowspan="2"><p>Gastrointestinal disorders</p></td><td><p>diarrhoea<sup>&Dagger;</sup>, nausea<sup>&Dagger;</sup>, vomiting<sup>&Dagger;</sup></p></td><td><p>Common</p></td></tr><tr><td><p>dry mouth, dyspepsia</p></td><td><p>Uncommon</p></td></tr><tr><td rowspan="2"><p>Hepatobiliary disorders</p></td><td><p>elevated levels of serum transaminases (ALT, AST)</p></td><td><p>Common</p></td></tr><tr><td><p>hepatitis (including cholestatic, hepatocellular, and mixed-pattern liver injury).</p></td><td><p>Very Rare</p></td></tr><tr><td rowspan="4"><p>Skin and subcutaneous tissue disorders</p></td><td><p>rash<sup>&Dagger;</sup></p></td><td><p>Common</p></td></tr><tr><td><p>bruising, urticaria, pruritus</p></td><td><p>Uncommon</p></td></tr><tr><td><p>angiooedema</p></td><td><p>Rare</p></td></tr><tr><td><p>erythema nodosum, erythema multiforme</p></td><td><p>Very Rare</p></td></tr><tr><td><p>Musculoskeletal and connective tissue disorders</p></td><td><p>arthralgia, myalgia including muscle cramps</p></td><td><p>Uncommon</p></td></tr><tr><td rowspan="2"><p>General disorders and administration site conditions</p></td><td><p>pyrexia<sup>&Dagger;</sup></p></td><td><p>Common</p></td></tr><tr><td><p>asthenia/fatigue, malaise, oedema</p></td><td><p>Uncommon</p></td></tr><tr><td colspan="3"><p>* Frequency Category: Defined for each Adverse Reaction by the incidence reported in the clinical trials data base:<br />Very Common (&ge;1/10), Common (&ge;1/100 to &lt;1/10), Uncommon (&ge;1/1,000 to &lt;1/100), Rare (&ge;1/10,000 to &lt;1/1,000), Very Rare (&lt;1/10,000).<br /><sup>&dagger;</sup> This adverse experience, reported as Very Common in the patients who received montelukast, was also reported as Very Common in the patients who received placebo in clinical trials.<br /><sup>&Dagger;</sup> This adverse experience, reported as Common in the patients who received montelukast, was also reported as Common in the patients who received placebo in clinical trials.<br /><sup>&sect;</sup> Frequency Category: Rare</p></td></tr></tbody></table><p><u>To reports any side effect(s):</u></p><ul><li><strong><em>Saudi Arabia:</em></strong></li></ul><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><ul><li>Fax: +966 11 2057662</li><li>SFDA Call Center: 19999</li><li>Email: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa</li></ul></td></tr></tbody></table><ul><li><strong><em>Other GCC States:</em></strong></li></ul><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td>Please contact the relevant competent authority.</td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In chronic asthma studies, montelukast has been administered at doses up to 200 mg/day to adult patients for 22 weeks and in short term studies, up to 900 mg/day to patients for approximately one week without clinically important adverse experiences.<br />There have been reports of acute overdose in post-marketing experience and clinical studies with montelukast. These include reports in adults and children with a dose as high as 1,000 mg (approximately 61 mg/kg in a 42-month old child).<br />The clinical and laboratory findings observed were consistent with the safety profile in adults and paediatric patients.<br />There were no adverse experiences in the majority of overdose reports.</p><p><u>Symptoms of overdose</u><br />The most frequently occurring adverse experiences were consistent with the safety profile of montelukast and included abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity.</p><p><u>Management of overdose</u><br />No specific information is available on the treatment of overdose with montelukast. It is not known whether montelukast is dialysable by peritoneal- or haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Leukotriene receptor antagonist<br />ATC-code: R03D C03</p><p><u>Mechanism of action</u><br />The cysteinyl leukotrienes (LTC<sub>4</sub>, LTD<sub>4</sub>, LTE<sub>4</sub>) are potent inflammatory eicosanoids released from various cells including mast cells and eosinophils. These important pro-asthmatic mediators bind to cysteinyl leukotriene (CysLT) receptors.<br />The CysLT type-1 (CysLT<sub>1</sub>) receptor is found in the human airway (including airway smooth muscle cells and airway macrophages) and on other pro-inflammatory cells (including eosinophils and certain myeloid stem cells). CysLTs have been correlated with the pathophysiology of asthma and allergic rhinitis. In asthma, leukotriene-mediated effects include bronchoconstriction, mucous secretion, vascular permeability, and eosinophil recruitment. In allergic rhinitis, CysLTs are released from the nasal mucosa after allergen exposure during both early- and late-phase reactions and are associated with symptoms of allergic rhinitis. Intranasal challenge with CysLTs has been shown to increase nasal airway resistance and symptoms of nasal obstruction.</p><p><u>Pharmacodynamic effects</u><br />Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT<sub>1</sub> receptor. In clinical studies, montelukast inhibits bronchoconstriction due to inhaled LTD<sub>4</sub> at doses as low as 5 mg. Bronchodilation was observed within 2 hours of oral administration. The bronchodilation effect caused by a &beta;-agonist was additive to that caused by montelukast. Treatment with montelukast inhibited both early- and late-phase bronchoconstriction due to antigen challenge. Montelukast, compared with placebo, decreased peripheral blood eosinophils in adult and paediatric patients. In a separate study, treatment with montelukast significantly decreased eosinophils in the airways (as measured in sputum) and in peripheral blood while improving clinical asthma control.</p><p><u>Clinical efficacy and safety</u><br />In studies in adults, montelukast, 10 mg once daily, compared with placebo, demonstrated significant improvements in morning FEV<sub>1</sub> (10.4% vs 2.7% change from baseline), AM peak expiratory flow rate (PEFR) (24.5 L/min vs 3.3 L/min change from baseline), and significant decrease in total &beta;-agonist use (-26.1% vs -4.6% change from baseline). Improvement in patient-reported daytime and nighttime asthma symptoms scores was significantly better than placebo.<br />Studies in adults demonstrated the ability of montelukast to add to the clinical effect of inhaled corticosteroid (% change from baseline for inhaled beclomethasone plus montelukast vs beclomethasone, respectively for FEV<sub>1</sub>: 5.43% vs 1.04%; &beta;-agonist use: -8.70% vs 2.64%). Compared with inhaled beclomethasone (200 &mu;g twice daily with a spacer device), montelukast demonstrated a more rapid initial response, although over the 12-week study, beclomethasone provided a greater average treatment effect (% change from baseline for montelukast vs beclomethasone, respectively for FEV<sub>1</sub>: 7.49% vs 13.3%; &beta;-agonist use: -28.28% vs -43.89%). However, compared with beclomethasone, a high percentage of patients treated with montelukast achieved similar clinical responses (e.g., 50% of patients treated with beclomethasone achieved an improvement in FEV<sub>1</sub> of approximately 11% or more over baseline while approximately 42% of patients treated with montelukast achieved the same response).<br />A clinical study was conducted to evaluate montelukast for the symptomatic treatment of seasonal allergic rhinitis in adult and adolescent asthmatic patients 15 years of age and older with concomitant seasonal allergic rhinitis. In this study, montelukast 10 mg tablets administered once daily demonstrated a statistically significant improvement in the Daily Rhinitis Symptoms score, compared with placebo. The Daily Rhinitis Symptoms score is the average of the Daytime Nasal Symptoms score (mean of nasal congestion, rhinorrhea, sneezing, nasal itching) and the Nighttime Symptoms score (mean of nasal congestion upon awakening, difficulty going to sleep, and nighttime awakenings scores). Global evaluations of allergic rhinitis by patients and physicians were significantly improved, compared with placebo. The evaluation of asthma efficacy was not a primary objective in this study.<br />In an 8-week study in paediatric patients 6 to 14 years of age, montelukast 5 mg once daily, compared with placebo, significantly improved respiratory function (FEV<sub>1</sub> 8.71% vs 4.16% change from baseline; AM PEFR 27.9 L/min vs 17.8 L/min change from baseline) and decreased &ldquo;as-needed&rdquo; &beta;-agonist use (-11.7% vs +8.2% change from baseline).<br />Significant reduction of exercise-induced bronchoconstriction (EIB) was demonstrated in a 12-week study in adults (maximal fall in FEV<sub>1</sub> 22.33% for montelukast vs 32.40% for placebo; time to recovery to within 5% of baseline FEV<sub>1</sub> 44.22 min vs 60.64 min). This effect was consistent throughout the 12-week study period. Reduction in EIB was also demonstrated in a short-term study in paediatric patients (maximal fall in FEV<sub>1</sub> 18.27% vs 26.11%; time to recovery to within 5% of baseline FEV<sub>1</sub> 17.76 min vs 27.98 min). The effect in both studies was demonstrated at the end of the once-daily dosing interval.<br />In aspirin-sensitive asthmatic patients receiving concomitant inhaled and/or oral corticosteroids, treatment with montelukast, compared with placebo, resulted in significant improvement in asthma control (FEV<sub>1</sub> 8.55% vs -1.74% change from baseline and decrease in total &beta;-agonist use -27.78% vs 2.09% change from baseline).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u><br />Montelukast is rapidly absorbed following oral administration. For the 10 mg film-coated tablet, the mean peak plasma concentration (C<sub>max</sub>) is achieved 3 hours (T<sub>max</sub>) after administration in adults in the fasted state. The mean oral bioavailability is 64%. The oral bioavailability and C<sub>max</sub> are not influenced by a standard meal. Safety and efficacy were demonstrated in clinical trials where the 10 mg film-coated tablet was administered without regard to the timing of food ingestion.</p><p><u>Distribution</u><br />Montelukast is more than 99% bound to plasma proteins. The steady-state volume of distribution of montelukast averages 8-11 litres. Studies in rats with radiolabelled montelukast indicate minimal distribution across the blood-brain barrier. In addition, concentrations of radiolabelled material at 24 hours post-dose were minimal in all other tissues.</p><p><u>Biotransformation</u><br />Montelukast is extensively metabolised. In studies with therapeutic doses, plasma concentrations of metabolites of montelukast are undetectable at steady state in adults and children.<br />Cytochrome P450 2C8 is the major enzyme in the metabolism of montelukast. Additionally, CYP 3A4 and 2C9 may have a minor contribution, although itraconazole, an inhibitor of CYP 3A4, was shown not to change pharmacokinetic variables of montelukast in healthy subjects that received 10 mg montelukast daily. Based on <em>in vitro </em>results in human liver microsomes, therapeutic plasma concentrations of montelukast do not inhibit cytochromes P450 3A4, 2C9, 1A2, 2A6, 2C19, or 2D6. The contribution of metabolites to the therapeutic effect of montelukast is minimal.</p><p><u>Elimination</u><br />The plasma clearance of montelukast averages 45 ml/min in healthy adults. Following an oral dose of radiolabeled montelukast, 86% of the radioactivity was recovered in 5-day faecal collections and &lt;0.2% was recovered in urine. Coupled with estimates of montelukast oral bioavailability, this indicates that montelukast and its metabolites are excreted almost exclusively via the bile.</p><p><u>Characteristics in Patients</u><br />No dosage adjustment is necessary for the elderly or mild to moderate hepatic insufficiency. Studies in patients with renal impairment have not been undertaken. Because montelukast and its metabolites are eliminated by the biliary route, no dose adjustment is anticipated to be necessary in patients with renal impairment. There are no data on the pharmacokinetics of montelukast in patients with severe hepatic insufficiency (Child-Pugh score &gt;9).<br />With high doses of montelukast (20- and 60-fold the recommended adult dose), decrease in plasma theophylline concentration was observed. This effect was not seen at the recommended dose of 10 mg once daily.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In animal toxicity studies, minor serum biochemical alterations in ALT, glucose, phosphorus and triglycerides were observed which were transient in nature. The signs of toxicity in animals were increased excretion of saliva, gastrointestinal symptoms, loose stools and ion imbalance. These occurred at dosages which provided &gt;17-fold the systemic exposure seen at the clinical dosage. In monkeys, the adverse effects appeared at doses from 150 mg/kg/day (&gt;232-fold the systemic exposure seen at the clinical dose). In animal studies, montelukast did not affect fertility or reproductive performance at systemic exposure exceeding the clinical systemic exposure by greater than 24-fold. A slight decrease in pup body weight was noted in the female fertility study in rats at 200 mg/kg/day (&gt;69-fold the clinical systemic exposure). In studies in rabbits, a higher incidence of incomplete ossification, compared with concurrent control animals, was seen at systemic exposure &gt;24-fold the clinical systemic exposure seen at the clinical dose. No abnormalities were seen in rats. Montelukast has been shown to cross the placental barrier and is excreted in breast milk of animals.<br />No deaths occurred following a single oral administration of montelukast sodium at doses up to 5,000 mg/kg in mice and rats (15,000 mg/m<sup>2</sup> and 30,000 mg/m<sup>2</sup> in mice and rats, respectively), the maximum dose tested. This dose is equivalent to 25,000 times the recommended daily adult human dose (based on an adult patient weight of 50 kg).<br />Montelukast was determined not to be phototoxic in mice for UVA, UVB or visible light spectra at doses up to 500 mg/kg/day (approximately &gt;200-fold based on systemic exposure).<br />Montelukast was neither mutagenic in <em>in vitro</em> and <em>in vivo</em> tests nor tumorigenic in rodent species.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose monohydrate<br />Microcrystalline cellulose<br />Croscarmellose sodium<br />Magnesium stearate<br />Film coating:<br />Opadry AMB 80W27179<br />Ethanol<br />Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Available as 28 film-coated tablets carton pack containing 4 aluminum/aluminum blister strips (7 tablets each).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Saudi Pharmaceutical Industries
P.O. Box No.: 355127, Riyadh 11383
Kingdom of Saudi Arabia.
Tel: (+96611) 2650450, 2650354
Fax: (+96611) 2650383
Email: info@saudi-pharma.net

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07/2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>